• September 2009
    • Sigmapharm successfully completes an FDA inspection focused on its current GMP status and a Pre-Approval-Inspection related to its ANDA No. 091004.

    • Sigmapharm files an Abbreviated New Drug Application (ANDA No. 200295).

  • July 2009

    Sigmapharm files an Abbreviated New Drug Application (ANDA No. 091619).

  • April 2009

    Sigmapharm launches, through Rising Pharmaceuticals, Inc., its 1st generic product, Amiloride Hydrochloride Tablets, USP 5 mg, which is the second approved generic equivalent to MIDAMOR® Tablets.

  • January 2009

    Sigmapharm receives FDA approval for generic Amiloride Hydrochloride Tablets, USP 5 mg, based on its ANDA No. 079133.  This is our 1st ANDA approval.